These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 19444087)

  • 1. Health-related quality of life in patients undergoing allogeneic stem cell transplantation after reduced intensity conditioning versus myeloablative conditioning.
    Andersson I; Ahlberg K; Stockelberg D; Brune M; Persson LO
    Cancer Nurs; 2009; 32(4):325-34. PubMed ID: 19444087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patients' perception of health-related quality of life during the first year after autologous and allogeneic stem cell transplantation.
    Andersson I; Ahlberg K; Stockelberg D; Persson LO
    Eur J Cancer Care (Engl); 2011 May; 20(3):368-79. PubMed ID: 20345452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased RBCTs after reduced intensity conditioning allogeneic stem cell transplantation: predictive value of prior Hb level.
    Ivanov V; Faucher C; Mohty M; Bilger K; Ladaique P; Sainty D; Arnoulet C; Chabannon C; Vey N; Camerlo J; Bouabdallah R; Maraninchi D; Bardou VJ; Blaise D
    Transfusion; 2004 Apr; 44(4):501-8. PubMed ID: 15043564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective study comparing the outcomes and health-related quality of life in adult patients with myeloid malignancies undergoing allogeneic transplantation using myeloablative or reduced-intensity conditioning.
    Gupta V; Panzarella T; Li L; Khan J; Sharma A; Lipton JH; Kuruvilla J; Messner H; Alibhai SM
    Biol Blood Marrow Transplant; 2012 Jan; 18(1):113-24. PubMed ID: 21703974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective study of health-related quality of life, fatigue, anxiety and depression 3-5 years after stem cell transplantation.
    Hjermstad MJ; Knobel H; Brinch L; Fayers PM; Loge JH; Holte H; Kaasa S
    Bone Marrow Transplant; 2004 Aug; 34(3):257-66. PubMed ID: 15170167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of life assessment in patients undergoing reduced intensity conditioning allogeneic as compared to autologous transplantation: results of a prospective study.
    Díez-Campelo M; Pérez-Simón JA; González-Porras JR; García-Cecilia JM; Salinero M; Caballero MD; Cañizo MC; Ocio EM; Miguel JF
    Bone Marrow Transplant; 2004 Oct; 34(8):729-38. PubMed ID: 15354204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced-intensity conditioning regimen preserves thymic function in the early period after hematopoietic stem cell transplantation.
    Jiménez M; Martínez C; Ercilla G; Carreras E; Urbano-Ispízua A; Aymerich M; Villamor N; Amézaga N; Rovira M; Fernández-Avilés F; Gaya A; Martino R; Sierra J; Montserrat E
    Exp Hematol; 2005 Oct; 33(10):1240-8. PubMed ID: 16219547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered sexual health and quality of life in women prior to hematopoietic cell transplantation.
    Tierney KD; Facione N; Padilla G; Blume K; Dodd M
    Eur J Oncol Nurs; 2007 Sep; 11(4):298-308. PubMed ID: 17196431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High response rate and improved graft-versus-host disease following bortezomib as salvage therapy after reduced intensity conditioning allogeneic stem cell transplantation for multiple myeloma.
    El-Cheikh J; Michallet M; Nagler A; de Lavallade H; Nicolini FE; Shimoni A; Faucher C; Sobh M; Revesz D; Hardan I; Fürst S; Blaise D; Mohty M
    Haematologica; 2008 Mar; 93(3):455-8. PubMed ID: 18287132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparable incidence and severity of cytomegalovirus infections following T cell-depleted allogeneic stem cell transplantation preceded by reduced intensity or myeloablative conditioning.
    Kalpoe JS; van der Heiden PL; Vaessen N; Claas EC; Barge RM; Kroes AC
    Bone Marrow Transplant; 2007 Jul; 40(2):137-43. PubMed ID: 17530007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of disseminated adenovirus infections using quantitative plasma PCR in adult allogeneic stem cell transplant recipients receiving reduced intensity or myeloablative conditioning.
    Kalpoe JS; van der Heiden PL; Barge RM; Houtzager S; Lankester AC; van Tol MJ; Kroes AC
    Eur J Haematol; 2007 Apr; 78(4):314-21. PubMed ID: 17331130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatigue and physical activity in patients undergoing hematopoietic stem cell transplant.
    Danaher EH; Ferrans C; Verlen E; Ravandi F; van Besien K; Gelms J; Dieterle N
    Oncol Nurs Forum; 2006 May; 33(3):614-24. PubMed ID: 16676017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Similar risks for chronic kidney disease in long-term survivors of myeloablative and reduced-intensity allogeneic hematopoietic cell transplantation.
    Al-Hazzouri A; Cao Q; Burns LJ; Weisdorf DJ; Majhail NS
    Biol Blood Marrow Transplant; 2008 Jun; 14(6):658-63. PubMed ID: 18489991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health-related quality of life in patients receiving reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation.
    Bevans MF; Marden S; Leidy NK; Soeken K; Cusack G; Rivera P; Mayberry H; Bishop MR; Childs R; Barrett AJ
    Bone Marrow Transplant; 2006 Jul; 38(2):101-9. PubMed ID: 16751786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The CARES-SF used for prospective assessment of health-related quality of life after stem cell transplantation.
    Hjermstad MJ; Evensen SA; Kvaløy SO; Loge JH; Fayers PM; Kaasa S
    Psychooncology; 2003 Dec; 12(8):803-13. PubMed ID: 14681953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regimen-related mucosal injury of the gut increased the incidence of CMV disease after allogeneic bone marrow transplantation.
    Shigematsu A; Yasumoto A; Yamamoto S; Sugita J; Kondo T; Onozawa M; Kahata K; Endo T; Ota S; Sato N; Takahata M; Okada K; Tanaka J; Hashino S; Nishio M; Koike T; Asaka M; Imamura M
    Biol Blood Marrow Transplant; 2009 Jun; 15(6):679-85. PubMed ID: 19450752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early and late neurological complications after reduced-intensity conditioning allogeneic stem cell transplantation.
    Barba P; Piñana JL; Valcárcel D; Querol L; Martino R; Sureda A; Briones J; Delgado J; Brunet S; Sierra J
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1439-46. PubMed ID: 19822304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reconstitution of the Ig heavy chain CDR3 repertoire after allogeneic haematopoietic stem cell transplantation with myeloablative or reduced-intensity conditioning regimens.
    Omazic B; Hentschke P; Näsman-Björk I; Mattsson J; Oxelius VA; Ringdén O; Barkholt L; Permert J; Lundkvist I
    Scand J Immunol; 2005 Jan; 61(1):72-81. PubMed ID: 15644125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequent and long-term follow-up of health-related quality of life following allogeneic haematopoietic stem cell transplantation.
    Frödin U; Lotfi K; Fomichov V; Juliusson G; Börjeson S
    Eur J Cancer Care (Engl); 2015 Nov; 24(6):898-910. PubMed ID: 26156141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advantages and limitations of (non-)myeloablative allogeneic stem cell transplantation.
    Huugen D; Schouten HC; Bos GM
    Neth J Med; 2002 May; 60(4):162-9. PubMed ID: 12164394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.